Sugammadex effectively reverses neuromuscular blockade in myasthenia gravis patients, ensuring rapid recovery and minimal complications. The review of 24 studies with 1679 patients showed no ...

OTTAWA — Established treatments such as thymectomy and steroids remain mainstays in the management of myasthenia gravis (MG), according to a presentation at the Canadian Neurological Sciences ...

Five therapies are currently approved by the FDA for treating the symptoms of myasthenia gravis, allowing partial to complete remission. Research suggests that five new therapies may become available ...

SAN FRANCISCO — Most patients with generalized myasthenia gravis (gMG) who took efgartigimod for 18 months managed to cut their glucocorticoid use to low levels or stopped taking it entirely, ...

Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

Myasthenia gravis is a lifelong (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...

This autoimmune disorder affects how well your nerves and muscles communicate, leading to a variety of symptoms. Myasthenia gravis (MG) is a chronic autoimmune condition that affects signaling between ...

Myasthenic crisis is a complication of myasthenia gravis (MG) that can cause a breathing emergency. Prevention can involve avoiding known triggers, such as infection, trauma, surgery, or medication ...

Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...